Evidence map›Paper›PMID 42779564›Full record

ReviewChildhood kidney diseases2024

Integrating predictive modeling and causal inference for advancing medical science.

Tae Ryom Oh

Abstract readReview
In one paragraph

Review in Childhood kidney diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Tae Ryom OhDepartment of Internal Medicine, Mokpo Hankook Hospital, Mokpo, Republic of Korea.ORCID 0000-0002-3713-0939

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) is revolutionizing healthcare by providing tools for disease prediction, diagnosis, and patient management. This review focuses on two key AI methodologies in healthcare: predictive modeling and causal inference. Predictive models excel in identifying patterns to forecast outcomes but are limited in explaining the underlying causes. In contrast, causal inference focuses on understanding cause-and-effect relationships, which makes effective medical interventions possible. Although randomized controlled trials (RCTs) are the gold standard for causal inference, they face limitations including cost and ethical concerns. As alternatives, emulated RCTs and advanced machine learning techniques have emerged for estimating causal effects, bridging the gap between prediction and causality. Additionally, Shapley values and Local Interpretable Model-Agnostic Explanations improve the interpretability of complex AI models, making them more actionable in clinical settings. Integrating prediction and causal inference holds great promise for advancing personalized medicine, enhancing patient outcomes, and optimizing healthcare delivery. However, careful application of AI tools is crucial to avoid misinterpretation and maximize their potential.

Indexed as

Artificial intelligenceCausalityForecasting

Identifiers

PMID42779564
PMCPMC13587166

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.